Continuing Treatment for Children and Adults in the Center for Cancer Research
N/A
N/A
Both
Acquired Immunodeficiency Syndrome, Neoplasm, Skin Disease, HIV Infections
Trial Information
Continuing Treatment for Children and Adults in the Center for Cancer Research
Background:
It may be in the interest of the CCR to continue to follow and treat certain subjects after
they have completed their treatment and participation on a research protocol.
Objective:
To provide continuing treatment and medical follow-up for CCR subjects who have completed
their treatment and participation on a research protocol and who are not currently entered
on or eligible for another active research protocol.
Eligibility:
Subjects who have been previously enrolled on and received treatment according to an
approved CCR research protocol. (clinical trial)
It is in the best interest of the subject and the CCR for the subject to continue to receive
standard care and follow-up at the NIH.
Design:
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects
who have completed their treatment and participation on a research protocol and who are not
currently entered on an active research protocol.
No investigational treatments will be administered. This protocol is not be used as a
platform to perform pilot studies of off-label uses for standard agents.
Inclusion Criteria
- INCLUSION CRITERIA:
Subjects of any age who have been previously enrolled and treated on an approved CCR
research treatment protocol.
It is in the best interests of the subject and the CCR for the subject to continue to
receive treatment and follow-up at the NIH.
The subject or guardian signs the informed consent and agrees to the proposed treatment
regimen.
EXCLUSION CRITERIA:
Subjects who have not been previously treated on a CCR research treatment protocol.
Subjects who are receiving an investigational therapy.
Type of Study:
Observational
Study Design:
N/A
Principal Investigator
Caryn Steakley, R.N.
Investigator Role:
Principal Investigator
Investigator Affiliation:
National Cancer Institute (NCI)
Authority:
United States: Federal Government
Study ID:
920094
NCT ID:
NCT00001295
Start Date:
January 1992
Completion Date:
Related Keywords:
- Acquired Immunodeficiency Syndrome
- Neoplasm
- Skin Disease
- HIV Infections
- Standard Care
- Follow-Up
- Bridge Protocol
- Acquired Immunodeficiency Syndrome
- HIV Infections
- Neoplasms
- Immunologic Deficiency Syndromes
- Skin Diseases
Name | Location |
|---|---|
| National Institutes of Health Clinical Center, 9000 Rockville Pike | Bethesda, Maryland 20892 |
